Livongo Health said today it will integrate continuous glucose data from Abbott‘s (NYSE:ABT) FreeStyle Libre Pro system into its Livongo for Diabetes system, touting it as the first such system to integrate data from Abbott’s system.
With the integration, users of the FreeStyle Libre Pro will be able to see a visual snapshot of their glucose data as well as patterns and trends from within the data. The system will also allow users to share their Ambulatory Glucose Profiles with personal physicians to improve treatment decisions.
Read the whole story on our sister site, Drug Delivery Business News